(VERA) - Analyzing Vera Therapeutics's Short Interest
Portfolio Pulse from Benzinga Insights
Vera Therapeutics (NYSE:VERA) has seen a decrease in short interest, with 6.05 million shares sold short, representing 17.98% of its float. The short interest has fallen by 3.75% since the last report, and it would take about 7.98 days to cover all short positions. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term price rise. Vera Therapeutics has a higher short interest compared to its peer group average of 11.66%.
January 31, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vera Therapeutics has experienced a decline in short interest, which could be a sign of increasing bullish sentiment among investors. However, the high short interest relative to peers suggests caution.
The decrease in short interest may suggest a more bullish sentiment towards VERA, but the stock's performance will depend on broader market conditions and company fundamentals. The high short interest relative to peers indicates that the market may still have concerns about the company's prospects, which could limit any potential upside from a short squeeze.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100